Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
ASML ASML Holding NV
FUN Cedar Fair LP
NWFFX American Funds New World Fund® Class F-1
CARS Cars.com Inc
AHT Ashford Hospitality Trust Inc
AHII Fyolo Technology Corp
AHH-A Armada Hoffler Properties Inc
AHH Armada Hoffler Properties Inc
AHFD Active Health Foods Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

Closing Price
$555.24
Day's Change
-9.76 (-1.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
567.83
Day's Low
544.96
Volume
(Heavy Day)
Volume:
1,977,113

10-day average volume:
856,718
1,977,113
  • Prev Close
    565.00
  • Today's Open
    567.48
  • Day's Range
    544.96-567.83
  • Avg Vol (10-day)
    856.7K
  • Last (time)
    3:59p ET 09/18/20
  • Last (size)
    1
  • 52-Wk Range
    271.37 - 664.64
    LowHigh
  • (09/27/19 - 07/20/20)
    16.46%
  • 41.8%
  • Market Cap
    59.1B
  • Shares Outstanding
    106.4M
  • 25.83
  • 21.50x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 88.41
  • (% of float 08/31/20)
    1.56

Latest News

September 16, 2020
5:43 am ET
Globe Newswire
September 15, 2020
12:00 pm ET
BusinessWire
September 14, 2020
9:30 am ET
Globe Newswire
7:00 am ET
PR Newswire
September 08, 2020
4:42 pm ET
MarketWatch
September 05, 2020
8:30 am ET
PR Newswire
September 03, 2020
7:00 am ET
PR Newswire
6:59 am ET
PR Newswire
September 01, 2020
8:39 am ET
MarketWatch
August 31, 2020
8:54 pm ET
Globe Newswire
August 29, 2020
10:13 pm ET
Globe Newswire
August 26, 2020
7:00 am ET
PR Newswire
August 22, 2020
9:19 pm ET
Globe Newswire
August 20, 2020
12:38 pm ET
Globe Newswire
7:17 am ET
MarketWatch
August 19, 2020
10:09 pm ET
PR Newswire
9:31 am ET
PR Newswire
August 16, 2020
12:09 am ET
Globe Newswire
August 12, 2020
7:00 am ET
PR Newswire
August 07, 2020
4:05 pm ET
PR Newswire
August 05, 2020
6:59 am ET
MarketWatch
6:43 am ET
MarketWatch
6:41 am ET
MarketWatch
6:40 am ET
MarketWatch
6:40 am ET
MarketWatch
6:40 am ET
MarketWatch
August 03, 2020
9:38 am ET
PR Newswire
8:30 am ET
BusinessWire
July 29, 2020
10:25 pm ET
PR Newswire
9:00 pm ET
PR Newswire
7:24 am ET
MarketWatch
7:00 am ET
PR Newswire
July 23, 2020
11:54 am ET
PR Newswire
July 22, 2020
8:20 pm ET
PR Newswire
July 20, 2020
10:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.